HealthStream, Inc. (NASDAQ:HSTM) Director C Martin Harris sold 525 shares of the business’s stock in a transaction dated Friday, May 18th. The stock was sold at an average price of $27.63, for a total transaction of $14,505.75. Following the transaction, the director now owns 24,269 shares in the company, valued at $670,552.47. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
C Martin Harris also recently made the following trade(s):
- On Monday, May 7th, C Martin Harris sold 3,415 shares of HealthStream stock. The stock was sold at an average price of $26.58, for a total transaction of $90,770.70.
- On Thursday, March 1st, C Martin Harris sold 10,452 shares of HealthStream stock. The stock was sold at an average price of $24.06, for a total transaction of $251,475.12.
HealthStream traded up $0.30, reaching $27.70, on Friday, according to MarketBeat.com. The company had a trading volume of 82,252 shares, compared to its average volume of 133,849. HealthStream, Inc. has a fifty-two week low of $21.15 and a fifty-two week high of $31.53. The firm has a market cap of $885.09 million, a P/E ratio of 88.39, a price-to-earnings-growth ratio of 5.35 and a beta of 0.75.
A number of institutional investors and hedge funds have recently made changes to their positions in HSTM. Stevens Capital Management LP acquired a new position in HealthStream in the 1st quarter valued at about $203,000. Victory Capital Management Inc. acquired a new position in HealthStream in the 1st quarter valued at about $210,000. Teacher Retirement System of Texas acquired a new position in HealthStream in the 4th quarter valued at about $215,000. Barclays PLC grew its stake in HealthStream by 45.6% in the 1st quarter. Barclays PLC now owns 9,444 shares of the technology company’s stock valued at $235,000 after buying an additional 2,958 shares during the last quarter. Finally, Campbell & CO Investment Adviser LLC acquired a new position in HealthStream in the 1st quarter valued at about $241,000. Institutional investors and hedge funds own 69.19% of the company’s stock.
Several research analysts have recently weighed in on the stock. ValuEngine lowered shares of HealthStream from a “hold” rating to a “sell” rating in a research note on Thursday, April 26th. Canaccord Genuity restated a “hold” rating and set a $26.00 price objective on shares of HealthStream in a research note on Wednesday, May 2nd. BidaskClub upgraded shares of HealthStream from a “sell” rating to a “hold” rating in a research note on Saturday, February 10th. Barrington Research set a $32.00 price objective on shares of HealthStream and gave the stock a “buy” rating in a research note on Thursday, May 3rd. Finally, William Blair restated an “outperform” rating on shares of HealthStream in a research note on Tuesday, February 13th. Five investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. HealthStream currently has a consensus rating of “Buy” and a consensus price target of $26.14.
HealthStream, Inc provides workforce and provider solutions to the healthcare organizations in the United States. It operates in HealthStream Workforce Solutions and HealthStream Provider Solutions segments. The company offers workforce development solutions comprising software-as-a-service (SaaS) and subscription-based products to meet talent management, training, certification, competency assessment, performance appraisal, and development needs, as well as training, implementation, and account management services.
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.